GLP-1 medications that revolutionized weight loss may also blunt cravings for alcohol, opioids, and nicotine. Early evidence suggests they could transform how addiction is treated. Credit: Shutterstock A promising group of medications already used to treat diabetes and obesity may also hold potential for tackling alcohol and drug addiction, according to a new study published in the Journal of the Endocrine Society . These drugs, called Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs), could